Articles tagged "Graft survival"

2015 American Transplant Congress
Impact of HLA Antibody Monitoring After Kidney Transplantation
S. Rao,¹ M. Ghanta,¹ H. Parekh,² A. Gillespie,¹ I. Lee,¹ S. Geier,² K. Lau,³ S. Karhadkar,³ A. Di Carlo,³ S. Constantinescu.¹
¹Nephrology, Temple Univesity School of Medicine, Philadelphia, PA; ²Pathology, Temple Univesity School of Medicine, Philadelphia, PA; ³Surgery, Temple Univesity School of Medicine, Philadelphia, PA.
The impact of donor specific antibodies (DSA) and optimal therapeutic intervention for DSA in kidney transplant (KT) recipients has been reported with variable results. We…
2015 American Transplant Congress
Integrated Clinical-Histological (ICH) Score System for the Evaluation of “Marginal” Donors in Kidney Transplantation
M. Fiorentino,¹ M. Rossini,¹ P. Gallo,¹ G. Castellano,¹ A. Schena,¹ G. Grandaliano,² P. Ditonno,³ M. Bataglia,³ L. Gesualdo.¹
¹Department of Emergency and Organ Transplantation, Nephrology, Dialysis and Transplantation Unit, University of Bari, Bari, Italy; ²Department of Medical and Surgical Sciences, Nephrology, Dialysis and Transplantation Unit, University of Foggia, Foggia, Italy; ³Department of Emergency and Organ Transplantation, Andrology, Urology and Renal Transplantation Unit, University of Bari, Bari, Italy.
INTRODUCTION: The organ shortage has led to increase the procurement of kidney from “marginal” donors and to improve the strategies to better evaluate the quality…
2015 American Transplant Congress
A Critical Analysis of the Impact of Socioeconomic Status on Racial Disparities in Kidney Transplantation
D. Taber, M. Gebregziabher, M. Hamedi, T. Srinivas, K. Chavin, P. Baliga, L. Egede.
Medical University of South Carolina, Charleston, SC.
Socioeconomic status (SES) is a significant determinant of health outcomes and may be an important component of racial disparities in kidney transplantation (KTX). While the…
2015 American Transplant Congress
Management of Pancreas Graft Splenic Vein Thrombosis: Is Conservative Management Safe?
J. Harbell,¹ T. Morgan,² V. Feldstein,² G. Roll,¹ A. Posselt,¹ S.-M. Kang,¹ S. Feng,¹ R. Hirose,¹ C. Freise,¹ P. Stock.¹
¹Surgery, University of California, San Francisco, San Francisco, CA; ²Radiology, University of California, San Francisco, San Francisco, CA.
Background: Prophylaxis for graft portal/splenic venous thrombosis following pancreas transplant varies between institutions. Similarly, treatment of venous thrombosis ranges from early re-exploration to conservative management…
2015 American Transplant Congress
Angiopoietin-2 Associates With Graft Failure and Mortality in Renal Transplant Recipients
W. Westendorp,¹ C. Keyser,² E. van den Berg,² C. Krikke,¹ H. van Goor,³ S. Bakker,² H. Leuvenink.¹
¹Surgery, Groningen Transplant Center, University Medical Center Groningen, Groningen, Netherlands; ²Nephrology, Groningen Transplant Center, University Medical Center Groningen, Groningen, Netherlands; ³Pathology, University Medical Center Groningen, Groningen, Netherlands.
Angiopoietin-1 (Ang1) and angiopoietin-2 (Ang2) are involved in stabilizing the vascular endothelium and may play a role in premature mortality and graft failure in renal…
2015 American Transplant Congress
Part II: Rates and Determinants of Progression for De Novo Donor-Specific Antibody Mediated Kidney Allograft Injury
C. Wiebe,^1,2 I. Gibson,³ D. Pochinco,² P. Birk,⁴ T. Blydt-Hansen,⁴ J. Ho,^1,5 M. Karpinski,¹ A. Goldberg,⁴ L. Storsley,¹ D. Rush,¹ P. Nickerson.^1,2,5
¹Medicine, University of Manitoba, Winnipeg, MB, Canada; ²Immunogenetics, Diagnostic Services of Manitoba, Winnipeg, MB, Canada; ³Pathology, University of Manitoba, Winnipeg, MB, Canada; ⁴Pediatric and Child Health, University of Manitoba, Winnipeg, MB, Canada; ⁵Immunology, University of Manitoba, Winnipeg, MB, Canada.
The development of de novo donor-specific antibody (dnDSA) is an independent predictor of allograft loss in renal transplantation. Rates and determinants of clinical pathologic progression…
2015 American Transplant Congress
Risk Associated With DCD Kidney Transplantation Varies by Donor Characteristics
X. Luo, A. Massie, E. Chow, D. Segev.
Johns Hopkins, Baltimore.
Studies have shown that comparable kidney graft survival between donors after brain death (DBD) and donors after circulatory death (DCD) overall. However, the differential risk…
2015 American Transplant Congress
Impact of Delayed Graft Function and Number of Dialysis Sessions on Graft Outcome After Kidney Transplantation
L. Lehner, A. Hohberger, L. Marschke, K. Zhang, F. Halleck, D. Khadzhynov, O. Staeck, M. Dürr, D. Schmidt, L. Liefeldt, K. Budde.
Dep.of Nephrology Charité Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany.
IntroductionDelayed graft function (DGF), defined as dialysis within the first week after kidney transplantation, is a common and known risk factor for impaired renal graft…
2015 American Transplant Congress
Outcomes of Treatment of Late Antibody-Mediated Rejection in Primary Renal Transplant Recipients – A Single Center Experience
R. Prashar, A. Patel, K. Venkat.
Division of Nephrology and Transplant Institute, Henry Ford Hospital, Detroit, MI.
Background: Successful reversal of early post-transplant antibody mediated rejection (AMR) is well documented, but data on the results of treatment of late AMR are lacking.…
2015 American Transplant Congress
Transplantation of Kidneys from Donors With Acute Renal Failure: Five-Year Results from Double Center Experience
C. Ramirez,^1,2 A. Safra,¹ A. Shah,^1,2 C. Doria,¹ W. Maley,¹ A. Frank,¹ C. Gorn,¹ L. Lerner.²
¹Department of Surgery, Division of Transplantation, Thomas Jefferson University Hospital, Philadelphia, PA; ²Department of Kidney Transplantation, Lankenau Medical Center, Wynnewood, PA.
Background: Transplantation of kidneys from deceased donors with acute renal failure (ARF) has been described and represents an underutilized source of renal grafts. We reviewed…